The Motley Fool

TSX:PLI (PROMETIC LIFE SCIENCES INC)

$13.60 $0.03 (0.00) Friday, October 4, 2019 at 3:59:18 p.m. Eastern Daylight Time

About

Last updated Oct 04, 2019, 03:59:18pm EDT
Current Price $13.60
Today's Change $0.03 (0%)
Close Price $13.60
Open Price $13.72
Bid $12.86
Ask $13.75
Day Range $13.29 - $13.72
Year Range $7.13 - $440.00
Volume 921
Average Volume 8,379
Market Cap $177,413,178.00
EPS (ttm) $-28.32

Related Articles

These Were the Worst-Performing Stocks on the TSX Last Week

Will Ashworth | July 8, 2019

The S&P/TSX Composite Index finished the week of July 2-5 with an increase of 0.98%, a little more than half the S&P 500. Here... More »

These Growth Stocks Could Surge With a New NAFTA Deal

Kenrick Vassall | September 12, 2018

Pharmaceutical companies such as Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) could benefit from a new NAFTA deal that includes longer data protection for biologic drugs. More »

4 Stocks That Have Taken Off This Year!

David Jagielski | February 2, 2018

North American Palladium Ltd. (TSX:PDL) and these three other stocks have soundly outperformed the market in 2018, but will these impressive results continue? More »

5 Stocks That Are Already up More Than 25% in 2018

David Jagielski | January 8, 2018

Aurora Cannabis Inc. (TSX:ACB) is off to a hot start in 2018, but you probably won't be able to guess the other four stocks on... More »

Are These 3 Stocks About to Take Off?

David Jagielski | October 17, 2017

ProMetic Life Sciences Inc. (TSX:PLI) and these two other stocks have seen strong recoveries after dismal starts to 2017. More »

ProMetic Life Sciences Inc. Jumps More Than 21% on FDA Designation

Chris MacDonald | August 29, 2017

ProMetic Life Sciences Inc.'s (TSX:PLI) plasminogen drug Ryplazimä has been granted a "Rare Pediatric Disease" designation by the U.S. Food and Drug Administration, renewing investor... More »

Can You Double Your Money With ProMetic Life Sciences Inc.?

Joey Frenette | January 4, 2017

ProMetic Life Sciences Inc. (TSX:PLI) has a great pipeline of impressive drugs. Could this be your ticket to huge profits in 2017? More »

Is Now the Time to Buy ProMetic Life Sciences Inc.?

Chris MacDonald | December 22, 2016

ProMetic Life Sciences Inc. (TSX:PLI) is a biopharmaceutical company with lots of potential upside given its current pipeline of drugs. More »

What Is Inflaming ProMetic Life Sciences Inc.’s Latest Increase?

Scott Brandt | October 25, 2016

ProMetic Life Sciences Inc.'s (TSX:PLI) stock climbed by more than 10% this month after its diabetes drug reported 100% success in phase two clinical... More »

Why ProMetic Life Sciences Shares Soared

Brian Pacampara, CFA | March 27, 2014

Is this meaningful? Or just another movement? More »